«The unique aspect of this approach is the ability to improve symptoms
and decrease joint damage while potentially avoiding any negative effects on normal immune responses
and susceptibility to infections,» adds co-author Gary S. Firestein, M.D., dean
and associate vice
chancellor of
Translational Medicine
and director of the
Clinical and Translational Research Institute at UCSD.